| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
35,410,000 |
| Market
Cap: |
13.82(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$202.16 - $413.31 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 463 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
34 |
| Total Shares Sold |
1,827,736 |
2,490,136 |
3,605,616 |
3,694,042 |
| Total Sell Value |
$734,360,254 |
$918,029,204 |
$1,190,266,600 |
$1,209,941,112 |
| Total People Sold |
6 |
6 |
8 |
8 |
| Total Sell Transactions |
45 |
71 |
88 |
95 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Medpace Investors, Llc |
10% Owner |
– – • |
2020-08-19 |
4 |
AS |
$127.63 |
$2,758,595 |
D/D |
(21,614) |
6,880,306 |
|
10% |
|
| Troendle August J. |
President & CEO |
• • • |
2020-08-18 |
4 |
AS |
$127.26 |
$2,111,116 |
I/I |
(16,589) |
6,901,920 |
|
8% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2020-08-18 |
4 |
AS |
$127.26 |
$2,111,116 |
D/D |
(16,589) |
6,901,920 |
|
8% |
|
| Geiger Jesse J |
CFO & COO, Lab Operations |
• – – |
2020-08-17 |
4 |
S |
$128.00 |
$448,000 |
D/D |
(3,500) |
6,382 |
|
-7% |
|
| Geiger Jesse J |
CFO & COO, Lab Operations |
• – – |
2020-08-17 |
4 |
OE |
$23.00 |
$80,500 |
D/D |
3,500 |
9,882 |
|
- |
|
| Troendle August J. |
President & CEO |
• • • |
2020-08-17 |
4 |
AS |
$128.18 |
$2,113,047 |
I/I |
(16,485) |
6,918,509 |
|
7% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2020-08-17 |
4 |
AS |
$128.18 |
$2,113,047 |
D/D |
(16,485) |
6,918,509 |
|
7% |
|
| Troendle August J. |
President & CEO |
• • • |
2020-08-14 |
4 |
AS |
$127.07 |
$2,142,019 |
I/I |
(16,857) |
6,934,994 |
|
9% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2020-08-14 |
4 |
AS |
$127.07 |
$2,142,019 |
D/D |
(16,857) |
6,934,994 |
|
9% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2020-08-13 |
4 |
AS |
$127.87 |
$2,131,721 |
D/D |
(16,671) |
6,951,851 |
|
8% |
|
| Troendle August J. |
President & CEO |
• • • |
2020-08-13 |
4 |
AS |
$127.87 |
$2,131,721 |
I/I |
(16,671) |
6,951,851 |
|
8% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2020-08-12 |
4 |
AS |
$127.21 |
$2,787,934 |
D/D |
(21,916) |
6,968,522 |
|
9% |
|
| Troendle August J. |
President & CEO |
• • • |
2020-08-12 |
4 |
AS |
$127.21 |
$2,787,934 |
I/I |
(21,916) |
6,968,522 |
|
9% |
|
| Troendle August J. |
President & CEO |
• • • |
2020-08-11 |
4 |
AS |
$125.30 |
$4,841,843 |
I/I |
(38,642) |
6,990,438 |
|
13% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2020-08-11 |
4 |
AS |
$125.30 |
$4,841,843 |
D/D |
(38,642) |
6,990,438 |
|
13% |
|
| Ewald Stephen P |
General Counsel & Corp. Secy. |
• – – |
2020-08-10 |
4 |
S |
$121.57 |
$899,618 |
D/D |
(7,400) |
3,336 |
|
-14% |
|
| Ewald Stephen P |
General Counsel & Corp. Secy. |
• – – |
2020-08-10 |
4 |
OE |
$23.00 |
$170,200 |
D/D |
7,400 |
10,736 |
|
- |
|
| Troendle August J. |
President & CEO |
• • • |
2020-08-10 |
4 |
AS |
$120.79 |
$5,815,797 |
I/I |
(48,148) |
7,029,080 |
|
14% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2020-08-10 |
4 |
AS |
$120.79 |
$5,815,797 |
D/D |
(48,148) |
7,029,080 |
|
14% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2020-08-07 |
4 |
AS |
$123.63 |
$2,465,429 |
D/D |
(19,942) |
7,077,228 |
|
12% |
|
| Troendle August J. |
President & CEO |
• • • |
2020-08-07 |
4 |
AS |
$123.63 |
$2,465,429 |
I/I |
(19,942) |
7,077,228 |
|
12% |
|
| Burwig Susan E |
Exec. VP, Operations |
• – – |
2020-08-06 |
4 |
S |
$126.00 |
$882,000 |
D/D |
(7,000) |
39,179 |
|
-22% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2020-08-06 |
4 |
AS |
$122.43 |
$1,840,490 |
D/D |
(15,033) |
7,097,170 |
|
22% |
|
| Troendle August J. |
President & CEO |
• • • |
2020-08-06 |
4 |
AS |
$122.43 |
$1,840,490 |
I/I |
(15,033) |
7,097,170 |
|
22% |
|
| Troendle August J. |
President & CEO |
• • • |
2020-08-05 |
4 |
AS |
$125.04 |
$1,647,902 |
I/I |
(13,179) |
7,112,203 |
|
16% |
|
533 Records found
|
|
Page 16 of 22 |
|
|
9.01 (2.26%) 
